Renaissance Technologies's EXAS Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 1.59 M shares of Exact Sciences Corporation (EXAS) worth $161.65 M, representing 0.25% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in EXAS, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 990,280 shares. Largest reduction occurred in Q3 2017, reducing 792,211 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +990,280 | Add 164.67% | 1.59 M | $101.56 |
| Q3 2025 | +72,572 | Add 13.72% | 601,376 | $54.71 |
| Q2 2025 | +494,904 | Add 1459.89% | 528,804 | $53.14 |
| Q1 2025 | +33,900 | New Buy | 33,900 | $43.29 |
| Q4 2024 | -64,600 | Sold Out | 0 | $0.00 |
| Q3 2024 | -446,104 | Reduce 87.35% | 64,600 | $68.12 |
| Q2 2024 | -477,200 | Reduce 48.30% | 510,704 | $42.25 |
| Q1 2024 | +37,000 | Add 3.89% | 987,904 | $69.06 |
| Q4 2023 | -336,881 | Reduce 26.16% | 950,904 | $73.98 |
| Q3 2023 | +678,485 | Add 111.35% | 1.29 M | $68.22 |
| Q2 2023 | +285,200 | Add 88.00% | 609,300 | $0.09 |
| Q1 2023 | +220,800 | Add 213.75% | 324,100 | $0.07 |
| Q4 2022 | +42,100 | Add 68.79% | 103,300 | $0.05 |
| Q3 2022 | +61,200 | New Buy | 61,200 | $32.48 |
| Q2 2021 | -82,904 | Sold Out | 0 | $0.00 |
| Q1 2021 | -527,300 | Reduce 86.41% | 82,904 | $131.78 |
| Q4 2020 | +467,874 | Add 328.72% | 610,204 | $132.49 |
| Q3 2020 | +142,330 | New Buy | 142,330 | $101.95 |
| Q4 2019 | -519,800 | Sold Out | 0 | $0.00 |
| Q3 2019 | +128,240 | Add 32.75% | 519,800 | $90.37 |
| Q2 2019 | +265,360 | Add 210.27% | 391,560 | $118.04 |
| Q1 2019 | +126,200 | New Buy | 126,200 | $86.62 |
| Q4 2018 | -249,198 | Sold Out | 0 | $0.00 |
| Q3 2018 | +162,898 | Add 188.76% | 249,198 | $78.92 |
| Q2 2018 | +86,300 | New Buy | 86,300 | $59.79 |
| Q4 2017 | -16,389 | Sold Out | 0 | $0.00 |
| Q3 2017 | -792,211 | Reduce 97.97% | 16,389 | $47.10 |
| Q2 2017 | +457,300 | Add 130.17% | 808,600 | $35.37 |
| Q1 2017 | +351,300 | New Buy | 351,300 | $23.62 |
| Q4 2016 | -365,300 | Sold Out | 0 | $0.00 |
| Q3 2016 | +365,300 | New Buy | 365,300 | $18.57 |
| Q2 2016 | -210,100 | Sold Out | 0 | $0.00 |
| Q1 2016 | +197,940 | Add 1627.80% | 210,100 | $6.74 |
| Q4 2015 | +12,160 | New Buy | 12,160 | $9.21 |
Renaissance Technologies's Exact Sciences Corporation Investment FAQs
Renaissance Technologies first purchased Exact Sciences Corporation (EXAS) in Q4 2015, acquiring 12,160 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Exact Sciences Corporation (EXAS) for 34 quarters since Q4 2015.
Renaissance Technologies's largest addition to Exact Sciences Corporation (EXAS) was in Q4 2025, adding 1,591,656 shares worth $161.65 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 1,591,656 shares of Exact Sciences Corporation (EXAS), valued at approximately $161.65 M.
As of the Q4 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.25% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Exact Sciences Corporation (EXAS) was 1,591,656 shares, as reported at the end of Q4 2025.